Glycover 0.2mg Injection
By Glycover
Rx
1ml Injection in a Vial

Composition
Glycopyrrolate(0.2mg)

Manufacturer - Verve Healthcare Ltd
VERVE HEALTH CARE LTD., A-43, (Basement), G.T. Karnal Road Indl. Area, New Delhi - 110033 (INDIA)

Expires on or after
October, 2025

liver
Limited information is accessible regarding the use of Glycover 0.2mg Injection in patients with liver disease. It is advisable to consult your doctor for appropriate guidance and potential risks associated with the injection.

kidney
Caution should be taken when using Glycover 0.2mg Injection in patients with kidney disease. It may require dose adjustment. Please consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Glycover 0.2mg Injection.

driving
Glycover 0.2mg Injection may impact vision and coordination, possibly affecting your driving skills. Be cautious as these side effects could hinder your ability to drive safely.

pregnancy
Glycover 0.2mg Injection is believed to be safe during pregnancy based on animal studies. Limited human studies are available, showing low risk to the baby.

breastfeeding
Glycover 0.2mg Injection appears safe during breastfeeding. Limited data shows no significant risk to the baby. Long-term use may decrease milk production.
Habit Forming | No |
Chemical Class | Synthetic Quaternary Ammonium |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Anticholinergic - Anaesthesia |
₹13.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024